Point-of-care Testing (POCT) for Tumor Marker - Global and China Top Players Market Share and Ranking 2023

According to YH Research, the global market for Point-of-care Testing (POCT) for Tumor Marker should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. 

By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Point-of-care Testing (POCT) for Tumor Marker market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Point-of-care Testing (POCT) for Tumor Marker market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. 

By segment, Hospital grew percent to account for percent of the total market sales, and lndependent Testing Organization grew percent. 

This report studies and analyses global Point-of-care Testing (POCT) for Tumor Marker status and future trends, helps the client to determine the Point-of-care Testing (POCT) for Tumor Marker market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Point-of-care Testing (POCT) for Tumor Marker, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year. 

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments. 

To assess the competitive environment within the market including supplier revenue, market share, and company profiles. 

Highlights 
(1) Global Point-of-care Testing (POCT) for Tumor Marker market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units) 
(2) Global Point-of-care Testing (POCT) for Tumor Marker sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units) 
(3) China Point-of-care Testing (POCT) for Tumor Marker sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units) 
(4) Global Point-of-care Testing (POCT) for Tumor Marker key consuming regions, consumption quantity, consumption value and demand structure 
(5) Global Point-of-care Testing (POCT) for Tumor Marker key producing regions, capacity, production, and year over year growth 
(6) Point-of-care Testing (POCT) for Tumor Marker industry chains, upstream, midstream and downstream 

Market segment by players, this report covers 
Roche 
Abbott 
BioMerieux 
Wondfo Biotech 
Yuwell 
Getein Biotech 
Beijing Wantai BioPharm 
Assure Tech 
Randox 
Orient Gene 
Hangzhou Biotest 
Shenzhen YHLO 
Qingdao Hightop Biotech Co., Ltd. 
Getein Biotech, Inc. 
Wuhan Easy Diagnosis Biomedicine Co.,ltd. 

Market segment by Type, covers 
Based on Immunochromatography 
Based on Chemiluminescence Technology 
Based on Biosensor 
Others 

Market segment by Application, can be divided into 
Hospital 
lndependent Testing Organization 

Market segment by regions, regional analysis covers 
North America (United States, Canada, and Mexico) 
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe) 
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific) 
South America (Brazil, Rest of South America) 
Middle East & Africa 

Report Includes: 

Chapter 1: to describe Point-of-care Testing (POCT) for Tumor Marker product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies. 

Chapter 2: Global Point-of-care Testing (POCT) for Tumor Marker market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023 

Chapter 3: China Point-of-care Testing (POCT) for Tumor Marker market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023 

Chapter 4: Global key producing regions of Point-of-care Testing (POCT) for Tumor Marker, percent & CAGR, 2018-2029 

Chapter 5: Point-of-care Testing (POCT) for Tumor Marker industry chain, upstream, medium-stream, and downstream. 

Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029 

Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029 

Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029 

Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029 

Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin. 

Chapter 11: Conclusions